menu
    • menu

    Company profile for Mabion SA

    NEW Drugs in Dev.: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mabion is the leading, polish biotechnology company founded in order to develop technology of biotechnological medicines production (based on the therapeutic monoclonal antibodies) and launch them on the market.The technology, independently developed in Mabion, enables production of targeted medicines that act selectively on cause of disease for example cancer cells, providing better efficiency and lower toxicity of the therap...
    Mabion is the leading, polish biotechnology company founded in order to develop technology of biotechnological medicines production (based on the therapeutic monoclonal antibodies) and launch them on the market.The technology, independently developed in Mabion, enables production of targeted medicines that act selectively on cause of disease for example cancer cells, providing better efficiency and lower toxicity of the therapy. Products under development: MabionCD20 biosimilar to MabThera, MabionHER2 biosimilar to Herceptin, MabionVEGF biosimilar to Avastin, MabionEGFR biosimilar to Erbitux, insulins and insulin analogs

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mabion SAPoland Flag
    Country
    Country
    Poland
    Address
    Address
    Mariana Langiewicza 60, 95-050 Konstantyn?w ??dzki, Poland
    Telephone
    Telephone
    48 422 908 210
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mabion.eu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mabion, NovalGen Partner to Bring NVG-222 to Market
    Mabion, NovalGen Partner to Bring NVG-222 to Market

    30 Jun 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/mabion-novalgen-partner-to-bring-nvg-222-to-market/

    CONTRACTPHARMA
    30 Jun 2025
    Share Share
    Mabion Launches €500,000 Oncology Services Contest
    Mabion Launches €500,000 Oncology Services Contest

    18 Jun 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/mabion-launches-e500000-oncology-services-contest/

    CONTRACTPHARMA
    18 Jun 2025
    Share Share
    Mabion Releases First NVG-222 Batch for Human Trials
    Mabion Releases First NVG-222 Batch for Human Trials

    17 Jun 2025

    // PRESS RELEASE

    https://www.mabion.eu/wp-content/uploads/2025/06/Leading-european-biologics-CDMO-Mabion-releases-first-batch-of-Novalgens-next-generation-T-cell-engager-NVG-222-for-first-in-human-clinical-trials-press-release.pdf

    PRESS RELEASE
    17 Jun 2025
    Share Share
    Mabion & WPD Pharma Collaborate on WPD-401 Analytical Methods
    Mabion & WPD Pharma Collaborate on WPD-401 Analytical Methods

    18 Apr 2025

    // PRESS RELEASE

    https://www.mabion.eu/wp-content/uploads/2025/04/Mabion-and-WPD-Pharmaceuticals-Initiate-Collaboration-on-Analytical-Method-Development-for-WPD-401-press-release.pdf

    PRESS RELEASE
    18 Apr 2025
    Share Share
    Mabion to fulfill CDMO orders for a new client – IBMP
    Mabion to fulfill CDMO orders for a new client – IBMP

    14 Apr 2025

    // PRESS RELEASE

    https://www.mabion.eu/wp-content/uploads/2025/04/Mabion-to-fulfill-CDMO-orders-for-a-new-client-%E2%80%93-IBMP-press-release.pdf

    PRESS RELEASE
    14 Apr 2025
    Share Share
    Sartorius & Mabion Partner to Boost Biopharma Development
    Sartorius & Mabion Partner to Boost Biopharma Development

    14 Apr 2025

    // PRESS RELEASE

    https://www.mabion.eu/wp-content/uploads/2025/04/Sartorius-and-Mabion-announce-strategic-cooperation-to-advance-biopharmaceutical-development-press-release.pdf

    PRESS RELEASE
    14 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search